STRN yields 0.20% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, STRN + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of STRN + MRK for your $10,000?
STRN is actively managed with exposure to large-cap companies listed on US exchanges. The investment universe begins with the 800 largest US equities, then narrowing it to the top 50% based on stock price momentum and intrinsic value analysis. Using proprietary quantitative ranking, the top 25% are further filtered by historical price momentum and performance trends. The final portfolio comprises 25 stocks weighted by market-cap, with individual positions capped at 8% and a minimum 1% position size. Sector exposure is limited to 30%. The fund utilizes third-party tools, public data, and industry trends to optimize risk-return characteristics in the aim of providing returns that may exceed those of the S&P 500 Index. Positions are reassessed monthly.
Full STRN Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.